A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the growth of pain-sensing nerves around tumours ...
The team at Zucker Hillside Hospital on the Queens-Nassau border will be administering cannabis, MDMA, commonly know as ecstasy or molly, and psilocybin, a compound in so-called "magic mushrooms." ...
Psilocybin-assisted therapy is legal in three states, but access has so far been limited and expensive. In the billion-dollar race to commercialize psychedelic medicine, psilocybin, a naturally ...
BOSTON — Two bills related to psilocybin — the active ingredient in so-called “magic mushrooms” — have moved forward in the Legislature. The Joint Committee on Public Health voted favorably to send ...
Email notifications are only sent once a day, and only if there are new matching items. The New Mexico Department of Health aims to launch the state’s highly anticipated medical psilocybin program by ...
Psilocybin, a naturally occurring psychedelic compound found in “magic mushrooms,” has been touted as a potential game-changer for depression and other psychiatric disorders. Over the past two decades ...
PORTLAND Ore. (KPTV) - A first-of-its-kind experiment conducted in Portland found that psilocybin can reverse the effects of traumatic brain injuries, according to researchers. MMA fighters from ...
AURORA, Colo — Researchers at UCHealth are conducting a clinical trial to determine whether psilocybin can ease anxiety and depression in advanced cancer patients. The National Cancer Institute-funded ...
Instead of using psychedelics as party drugs or for “wild trips,” researchers are testing them as serious tools for people facing mortality and not finding relief in standard treatments. Researchers ...
Psilocybe cubensis, a mushroom that produces the psychoactive compound psilocybin. Felix Blei / Leibniz-HKI Researchers don’t know exactly how psilocybin, a psychoactive compound found in psychedelic ...
Researchers from Stanford University School of Medicine, Université de Montréal, the University of Vermont, McGill University, and the Jewish General Hospital followed a 51-year-old man with ...